Media
Publications:
Documents:
Videos:
Audio/Podcasts:
Biography
Dr. Eva Polverino is a pulmonologist expert in respiratory infections affiliated with the European Respiratory Society.
Areas of Expertise (4)
Vaccination
Pulmonary Diseases
Medicine
Research
Education (1)
University of Pisa: M.D., Medicine, Pulmonary Disease Residency Program 2002
Affiliations (1)
- European Respiratory Society
Languages (1)
- English
Featured Articles (5)
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomize...
American Medical Association
2015 Importance In patients with severe community-acquired pneumonia, treatment failure is associated with excessive inflammatory response and worse outcomes. Corticosteroids may modulate cytokine release in these patients, but the benefit of this adjunctive therapy remains controversial.
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
European Respiratory Journal
2013 This phase II, randomised, double-blind, multicentre study (NCT00930982) investigated the safety and efficacy of ciprofloxacin dry powder for inhalation (DPI) in patients with non-cystic fibrosis bronchiectasis.
Microbial aetiology of community-acquired pneumonia and its relation to severity
BMJ Journals Thorax
2011 The distribution of the microbial aetiology and mortality of community-acquired pneumonia (CAP) was investigated in relation to the clinical setting and severity scores (pneumonia severity index (PSI) and confusion, blood urea nitrogen, respiratory rate, blood pressure, age (CURB-65).
Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations
BMJ Journals Thorax
2011 Since the first British Thoracic Society (BTS) recommendations published in 2002 and web update in 2004, data from several studies have confirmed previous findings suggesting that neither resting sea level oxygen saturations nor forced expiratory volume in 1 s (FEV1) reliably predict hypoxaemia or complications of air travel in passengers with respiratory disease. It is thus now clear that there is no reliable threshold in these variables to determine accurately the safety of air travel or need for in-flight oxygen in an individual patient. Nevertheless, the need for practical recommendations remains. The new guidance covers bronchiectasis, cancer, hyperventilation and dysfunctional breathing, obesity, pulmonary arteriovenous malformations and sinus and middle ear disease, and has expanded sections on infection and comorbidity with cardiac disease.
Severe Community-Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission
Clinical Infectious Diseases
2009 The recent Infectious Disease Society of America/American Thoracic Society guidelines for the management of community-acquired pneumonia (CAP) in adults defined a predictive rule to identify patients with severe CAP to determine the need for intensive care unit (ICU) admission. We clinically validated this rule.
Social